查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1873370

臨床試驗影像：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Clinical Trial Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 129 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球臨床試驗診斷影像市場規模估計為 15.79 億美元，預計到 2031 年將達到 25.01 億美元，2025 年至 2031 年的複合年成長率為 6.9%。

臨床試驗影像學是指在臨床試驗過程中，利用X光、CT掃描和MRI掃描等影像技術觀察分析受試者體內狀況的過程。它在評估新藥、治療方法和醫療設備的療效、安全性和副作用方面發揮著不可替代的作用。影像技術使研究人員能夠直覺地觀察藥物在體內的分佈、代謝和作用機制，為藥物的臨床應用提供科學基礎。

全球領先的臨床試驗影像設備製造商包括Clario、ICON、MacLaren、Calix和BioTelemetry。前五大公司佔據了約60%的市場。北美市佔率最大，約33%，其次是歐洲和亞太地區，各佔約27%。依產品類型分類，中心影像服務是最大的細分市場，約佔70%的市場。按應用領域分類，製藥公司是最大的用戶，其次是生技公司。

臨床試驗影像檢查流程必須嚴格遵守倫理原則和監管要求。研究者必須確保受試者的知情同意權得到充分保障，並在試驗過程中嚴格遵循科學原則和倫理標準。同時，監管機構必須加強對臨床試驗影像檢查的監管，以確保試驗結果的可靠性和有效性。

臨床試驗影像在藥物研發的不同階段都扮演著重要角色。例如，在I期臨床試驗中，影像技術可用於觀察藥物在體內的藥物動力學特性。在II/III期臨床試驗中，則可用於評估藥物的療效和安全性。

對於新型醫療設備，臨床試驗影像可用於評估其性能、安全性和臨床應用價值。將新型器材的有效性與現有器材進行比較，可以為醫療設備的推廣和應用提供強而有力的支援。

在臨床試驗中，影像技術也用於早期診斷、後續觀察和療效評估。例如，在腫瘤治療中，定期影像檢查可以觀察腫瘤的大小、形態和變化，從而及時調整治療方案。

隨著醫療技術的不斷進步和臨床試驗需求的日益成長，臨床試驗影像診斷市場預計將迎來更廣闊的發展前景。未來，該領域可望更加重視技術創新和個人化服務的開發，以滿足各類臨床試驗的需求。

臨床試驗影像市場的主要促進因素包括：

技術進步：創新驅動核心成長

高精度、多模態診斷影像技術

MRI、CT 和 PET 等技術突破：高解析度成像技術（如 3T MRI 和超低劑量 CT）提供更準確的解剖和功能資訊，有助於更早診斷疾病和評估療效。

多模態融合：CT-MRI 和 PET-CT 融合技術結合了解剖和代謝訊息，顯著提高了診斷敏感性，例如在腫瘤分期中。

人工智慧與自動化

人工智慧輔助分析：深度學習演算法可自動偵測病灶（例如肺結節和乳房鈣化），從而減少人為錯誤並提高診斷效率。

流程自動化：人工智慧驅動的掃描通訊協定最佳化和自動報告產生可縮短臨床試驗週期並降低成本。

攜帶式即時診斷成像

攜帶式超音波設備：適用於床邊檢查和偏遠地區，擴大了臨床試驗的範圍。

即時成像技術，例如超音波彈性成像，可以動態監測組織硬度的變化，並為肝纖維化等疾病提供即時回饋。

政策支持：營造有利的發展環境

完善法規結構

FDA 和 NMPA 等機構：透過嚴格的核准程序確保設備的安全性和有效性（例如，III 類醫療影像設備在註冊前必須經過臨床試驗）。

國際標準的協調：促進影像通訊協定和資料標準化（例如 DICOM 格式），以促進多中心研究資料的共用。

資金和獎勵

政府科研經費：例如，中國的「十四五」規劃為加速醫學影像技術的科技轉型提供了專案支援。

稅收優惠和補貼：為鼓勵企業進行研發和創新，將提供財政補貼，例如，對在國內生產高階診斷成像設備的計劃提供補貼。

醫療需求成長：人口結構與疾病結構的變化

老化與慢性病負擔

癌症和神經退化性疾病發生率高：全球癌症發生率不斷上升，推動了對早期篩檢和治療反應監測的需求。

對精準醫療的需求：個人化治療依賴高精度影像（例如，用於標靶治療的分子影像）。

擴大新藥研發與臨床試驗

創新藥物研發蓬勃發展：全球正在研發的新藥數量呈現爆炸性成長，帶動了臨床試驗中影像需求的相應增加。

罕見疾病和真實世界研究：影像技術支援小規模樣本試驗和長期療效追蹤。

臨床試驗影像市場的成長受到技術創新、政策影響、日益精細化的需求以及不斷演變的競爭格局的驅動。展望未來，人工智慧、多模態成像和雲端技術的深度融合將加速市場朝向更高智慧化和精準化方向發展。同時，當地企業的崛起有望重塑全球競爭格局，並為產業注入新的活力。

本報告旨在對全球臨床試驗影像市場進行全面分析，重點關注總收入、市場佔有率和主要企業的排名，並按地區/國家、類型和應用對臨床試驗影像進行分析。

本報告以收益為準，以2024年為基準年，對臨床試驗影像市場規模、估算和預測進行了闡述，並涵蓋了2020年至2031年的歷史數據和預測數據。定量和定性分析旨在幫助讀者制定業務和成長策略，評估競爭格局，分析公司在當前市場中的地位，並就臨床試驗影像相關事宜做出明智的商業決策。

市場區隔

公司

  • ICON
  • ERT
  • McLaren
  • Bioclinica
  • Parexel
  • BioTelemetry
  • ProScan Imaging
  • Imaging Endpoints
  • Radiant Sage
  • Micron, Inc.
  • Intrinsic Imaging
  • Median Technologies
  • Cardiovascular Imaging Technologies
  • Banook Medical
  • IXICO
  • Tigermed
  • Runda Medical
  • Konica Minolta
  • Keosys

按類型分類的細分市場

  • 內部圖像服務
  • 中央圖像服務

應用領域

  • 製藥公司
  • 生技公司
  • 學術機構
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Clinical Trial Imaging was estimated to be worth US$ 1579 million in 2024 and is forecast to a readjusted size of US$ 2501 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.

Clinical trial imaging refers to the process of using imaging technology (such as X-ray, CT, MRI, etc.) to observe and analyze the subjects in vivo during clinical trials. It plays an irreplaceable role in evaluating the efficacy, safety and side effects of new drugs, treatments or medical devices. Through imaging technology, researchers can intuitively observe the distribution, metabolism and mechanism of action of drugs in the body, providing a scientific basis for the clinical application of drugs.

The core manufacturers of clinical trial imaging in the world include Clario, ICON, McLaren, Calyx and BioTelemetry. The top five companies hold about 60% of the shares. North America is the largest market, with a share of about 33%, followed by Europe and Asia Pacific, each with a share of about 27%. In terms of product type, central imaging services are the largest market segment, with a share of about 70%. In terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.

In the process of clinical trial imaging, ethical principles and regulatory requirements must be strictly followed. Researchers need to ensure that the informed consent rights of subjects are fully guaranteed and that scientific principles and ethical standards are strictly followed during the trial. At the same time, regulatory agencies also need to strengthen the supervision of clinical trial imaging to ensure the reliability and validity of trial results.

Clinical trial imaging plays an important role in different stages of drug development. For example, in Phase I clinical trials, imaging technology can be used to observe the pharmacokinetic characteristics of drugs in the human body; in Phase II/III clinical trials, the efficacy and safety of drugs can be evaluated.

For new medical devices, clinical trial imaging can be used to evaluate their performance, safety and clinical application value. By comparing the effects of using new equipment with existing equipment, strong support can be provided for the promotion and application of medical equipment.

In clinical trials, imaging technology can also be used for early diagnosis of diseases, disease monitoring and evaluation of treatment effects. For example, in tumor treatment, regular imaging examinations can be used to observe the size, morphology and changes of tumors, so as to adjust the treatment plan in time.

With the continuous advancement of medical technology and the increasing demand for clinical trials, the clinical trial imaging market will usher in a broader development prospect. In the future, this field will pay more attention to the development of technological innovation and personalized services to meet the needs of different clinical trials.

The driving factors of the clinical trial imaging market mainly include the following:

Technological progress: innovation drives core growth

High-precision and multimodal imaging technology

Breakthroughs in technologies such as MRI, CT, and PET: High-resolution imaging technology (such as 3T MRI and ultra-low-dose CT) provides more accurate anatomical and functional information, which helps early diagnosis of diseases and efficacy evaluation.

Multimodal fusion: The fusion technology of CT and MRI, PET and CT, combined with anatomical and metabolic information, significantly improves diagnostic sensitivity, such as in tumor staging.

Artificial Intelligence and Automation

AI-assisted analysis: Deep learning algorithms can automatically detect lesions (such as lung nodules and breast calcifications), reduce human errors, and improve diagnostic efficiency.

Process Automation: AI optimizes scanning protocols and automatically generates reports, shortens clinical trial cycles, and reduces costs.

Portable and Real-time Imaging

Portable ultrasound equipment: Suitable for bedside examinations and remote areas, expanding the coverage of clinical trials.

Real-time imaging technology: such as ultrasound elastic imaging, dynamically monitors changes in tissue hardness, and provides instant feedback for diseases such as liver fibrosis.

Policy support: Create a favorable development environment

Improvement of regulatory framework

FDA, NMPA and other agencies: Ensure the safety and effectiveness of equipment through strict approval processes, such as requiring that Class III medical imaging equipment must pass clinical trials before registration.

International Standard Coordination: Promote imaging protocols and data standardization (such as DICOM format) and promote multi-center trial data sharing.

Funding and Incentives

Government research funding: For example, China's "14th Five-Year Plan" special support for medical imaging technology to accelerate technology transformation.

Tax incentives and subsidies: Encourage corporate R&D and innovation, such as providing financial subsidies for localization projects of high-end imaging equipment.

Growth in medical demand: changes in population and disease structure

Aging and chronic disease burden

High incidence of cancer and neurodegenerative diseases: The global incidence of cancer is rising, driving the demand for early screening and efficacy monitoring.

Demand for precision medicine: Individualized treatment relies on high-precision imaging (such as molecular imaging in tumor targeted therapy).

New drug development and clinical trial expansion

Innovative drug development boom: The number of new drugs under development has surged globally, and the demand for imaging in clinical trials has increased accordingly.

Rare diseases and real-world research: Imaging technology helps small sample size trials and long-term efficacy tracking.

The growth of the clinical trial imaging market is the result of technological innovation, policy dividends, demand upgrades and the evolution of the competitive landscape. In the future, with the deep integration of AI, multimodal imaging and cloud technology, the market will accelerate its development towards intelligence and precision. At the same time, the rise of local companies will reshape the global competitive landscape and inject new vitality into the industry.

This report aims to provide a comprehensive presentation of the global market for Clinical Trial Imaging, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Clinical Trial Imaging by region & country, by Type, and by Application.

The Clinical Trial Imaging market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Imaging.

Market Segmentation

By Company

  • ICON
  • ERT
  • McLaren
  • Bioclinica
  • Parexel
  • BioTelemetry
  • ProScan Imaging
  • Imaging Endpoints
  • Radiant Sage
  • Micron, Inc.
  • Intrinsic Imaging
  • Median Technologies
  • Cardiovascular Imaging Technologies
  • Banook Medical
  • IXICO
  • Tigermed
  • Runda Medical
  • Konica Minolta
  • Keosys

Segment by Type

  • In-house Imaging Service
  • Central Imaging Service

Segment by Application

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic Institutes
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Clinical Trial Imaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Clinical Trial Imaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Clinical Trial Imaging in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Clinical Trial Imaging Product Introduction
  • 1.2 Global Clinical Trial Imaging Market Size Forecast (2020-2031)
  • 1.3 Clinical Trial Imaging Market Trends & Drivers
    • 1.3.1 Clinical Trial Imaging Industry Trends
    • 1.3.2 Clinical Trial Imaging Market Drivers & Opportunity
    • 1.3.3 Clinical Trial Imaging Market Challenges
    • 1.3.4 Clinical Trial Imaging Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Clinical Trial Imaging Players Revenue Ranking (2024)
  • 2.2 Global Clinical Trial Imaging Revenue by Company (2020-2025)
  • 2.3 Key Companies Clinical Trial Imaging Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Clinical Trial Imaging Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Clinical Trial Imaging
  • 2.6 Clinical Trial Imaging Market Competitive Analysis
    • 2.6.1 Clinical Trial Imaging Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Clinical Trial Imaging Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Imaging as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 In-house Imaging Service
    • 3.1.2 Central Imaging Service
  • 3.2 Global Clinical Trial Imaging Sales Value by Type
    • 3.2.1 Global Clinical Trial Imaging Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Clinical Trial Imaging Sales Value, by Type (2020-2031)
    • 3.2.3 Global Clinical Trial Imaging Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Pharmaceutical Companies
    • 4.1.2 Biotechnology Companies
    • 4.1.3 Academic Institutes
    • 4.1.4 Others
  • 4.2 Global Clinical Trial Imaging Sales Value by Application
    • 4.2.1 Global Clinical Trial Imaging Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Clinical Trial Imaging Sales Value, by Application (2020-2031)
    • 4.2.3 Global Clinical Trial Imaging Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Clinical Trial Imaging Sales Value by Region
    • 5.1.1 Global Clinical Trial Imaging Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Clinical Trial Imaging Sales Value by Region (2020-2025)
    • 5.1.3 Global Clinical Trial Imaging Sales Value by Region (2026-2031)
    • 5.1.4 Global Clinical Trial Imaging Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Clinical Trial Imaging Sales Value, 2020-2031
    • 5.2.2 North America Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Clinical Trial Imaging Sales Value, 2020-2031
    • 5.3.2 Europe Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Clinical Trial Imaging Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Clinical Trial Imaging Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Clinical Trial Imaging Sales Value, 2020-2031
    • 5.5.2 South America Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Clinical Trial Imaging Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Clinical Trial Imaging Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Clinical Trial Imaging Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Clinical Trial Imaging Sales Value, 2020-2031
    • 6.3.2 United States Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Clinical Trial Imaging Sales Value, 2020-2031
    • 6.4.2 Europe Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Clinical Trial Imaging Sales Value, 2020-2031
    • 6.5.2 China Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Clinical Trial Imaging Sales Value, 2020-2031
    • 6.6.2 Japan Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Clinical Trial Imaging Sales Value, 2020-2031
    • 6.7.2 South Korea Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Clinical Trial Imaging Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Clinical Trial Imaging Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Clinical Trial Imaging Sales Value, 2020-2031
    • 6.9.2 India Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Clinical Trial Imaging Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 ICON
    • 7.1.1 ICON Profile
    • 7.1.2 ICON Main Business
    • 7.1.3 ICON Clinical Trial Imaging Products, Services and Solutions
    • 7.1.4 ICON Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.1.5 ICON Recent Developments
  • 7.2 ERT
    • 7.2.1 ERT Profile
    • 7.2.2 ERT Main Business
    • 7.2.3 ERT Clinical Trial Imaging Products, Services and Solutions
    • 7.2.4 ERT Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.2.5 ERT Recent Developments
  • 7.3 McLaren
    • 7.3.1 McLaren Profile
    • 7.3.2 McLaren Main Business
    • 7.3.3 McLaren Clinical Trial Imaging Products, Services and Solutions
    • 7.3.4 McLaren Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.3.5 McLaren Recent Developments
  • 7.4 Bioclinica
    • 7.4.1 Bioclinica Profile
    • 7.4.2 Bioclinica Main Business
    • 7.4.3 Bioclinica Clinical Trial Imaging Products, Services and Solutions
    • 7.4.4 Bioclinica Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Bioclinica Recent Developments
  • 7.5 Parexel
    • 7.5.1 Parexel Profile
    • 7.5.2 Parexel Main Business
    • 7.5.3 Parexel Clinical Trial Imaging Products, Services and Solutions
    • 7.5.4 Parexel Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Parexel Recent Developments
  • 7.6 BioTelemetry
    • 7.6.1 BioTelemetry Profile
    • 7.6.2 BioTelemetry Main Business
    • 7.6.3 BioTelemetry Clinical Trial Imaging Products, Services and Solutions
    • 7.6.4 BioTelemetry Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.6.5 BioTelemetry Recent Developments
  • 7.7 ProScan Imaging
    • 7.7.1 ProScan Imaging Profile
    • 7.7.2 ProScan Imaging Main Business
    • 7.7.3 ProScan Imaging Clinical Trial Imaging Products, Services and Solutions
    • 7.7.4 ProScan Imaging Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.7.5 ProScan Imaging Recent Developments
  • 7.8 Imaging Endpoints
    • 7.8.1 Imaging Endpoints Profile
    • 7.8.2 Imaging Endpoints Main Business
    • 7.8.3 Imaging Endpoints Clinical Trial Imaging Products, Services and Solutions
    • 7.8.4 Imaging Endpoints Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Imaging Endpoints Recent Developments
  • 7.9 Radiant Sage
    • 7.9.1 Radiant Sage Profile
    • 7.9.2 Radiant Sage Main Business
    • 7.9.3 Radiant Sage Clinical Trial Imaging Products, Services and Solutions
    • 7.9.4 Radiant Sage Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Radiant Sage Recent Developments
  • 7.10 Micron, Inc.
    • 7.10.1 Micron, Inc. Profile
    • 7.10.2 Micron, Inc. Main Business
    • 7.10.3 Micron, Inc. Clinical Trial Imaging Products, Services and Solutions
    • 7.10.4 Micron, Inc. Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Micron, Inc. Recent Developments
  • 7.11 Intrinsic Imaging
    • 7.11.1 Intrinsic Imaging Profile
    • 7.11.2 Intrinsic Imaging Main Business
    • 7.11.3 Intrinsic Imaging Clinical Trial Imaging Products, Services and Solutions
    • 7.11.4 Intrinsic Imaging Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Intrinsic Imaging Recent Developments
  • 7.12 Median Technologies
    • 7.12.1 Median Technologies Profile
    • 7.12.2 Median Technologies Main Business
    • 7.12.3 Median Technologies Clinical Trial Imaging Products, Services and Solutions
    • 7.12.4 Median Technologies Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Median Technologies Recent Developments
  • 7.13 Cardiovascular Imaging Technologies
    • 7.13.1 Cardiovascular Imaging Technologies Profile
    • 7.13.2 Cardiovascular Imaging Technologies Main Business
    • 7.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Products, Services and Solutions
    • 7.13.4 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Cardiovascular Imaging Technologies Recent Developments
  • 7.14 Banook Medical
    • 7.14.1 Banook Medical Profile
    • 7.14.2 Banook Medical Main Business
    • 7.14.3 Banook Medical Clinical Trial Imaging Products, Services and Solutions
    • 7.14.4 Banook Medical Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Banook Medical Recent Developments
  • 7.15 IXICO
    • 7.15.1 IXICO Profile
    • 7.15.2 IXICO Main Business
    • 7.15.3 IXICO Clinical Trial Imaging Products, Services and Solutions
    • 7.15.4 IXICO Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.15.5 IXICO Recent Developments
  • 7.16 Tigermed
    • 7.16.1 Tigermed Profile
    • 7.16.2 Tigermed Main Business
    • 7.16.3 Tigermed Clinical Trial Imaging Products, Services and Solutions
    • 7.16.4 Tigermed Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.16.5 Tigermed Recent Developments
  • 7.17 Runda Medical
    • 7.17.1 Runda Medical Profile
    • 7.17.2 Runda Medical Main Business
    • 7.17.3 Runda Medical Clinical Trial Imaging Products, Services and Solutions
    • 7.17.4 Runda Medical Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.17.5 Runda Medical Recent Developments
  • 7.18 Konica Minolta
    • 7.18.1 Konica Minolta Profile
    • 7.18.2 Konica Minolta Main Business
    • 7.18.3 Konica Minolta Clinical Trial Imaging Products, Services and Solutions
    • 7.18.4 Konica Minolta Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.18.5 Konica Minolta Recent Developments
  • 7.19 Keosys
    • 7.19.1 Keosys Profile
    • 7.19.2 Keosys Main Business
    • 7.19.3 Keosys Clinical Trial Imaging Products, Services and Solutions
    • 7.19.4 Keosys Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)
    • 7.19.5 Keosys Recent Developments

8 Industry Chain Analysis

  • 8.1 Clinical Trial Imaging Industrial Chain
  • 8.2 Clinical Trial Imaging Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Clinical Trial Imaging Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Clinical Trial Imaging Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Clinical Trial Imaging Market Trends
  • Table 2. Clinical Trial Imaging Market Drivers & Opportunity
  • Table 3. Clinical Trial Imaging Market Challenges
  • Table 4. Clinical Trial Imaging Market Restraints
  • Table 5. Global Clinical Trial Imaging Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Clinical Trial Imaging Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Clinical Trial Imaging Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Clinical Trial Imaging Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Clinical Trial Imaging
  • Table 10. Global Clinical Trial Imaging Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Imaging as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Clinical Trial Imaging Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Clinical Trial Imaging Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Clinical Trial Imaging Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Clinical Trial Imaging Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Clinical Trial Imaging Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Clinical Trial Imaging Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Clinical Trial Imaging Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Clinical Trial Imaging Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Clinical Trial Imaging Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Clinical Trial Imaging Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Clinical Trial Imaging Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Clinical Trial Imaging Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Clinical Trial Imaging Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Clinical Trial Imaging Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Clinical Trial Imaging Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Clinical Trial Imaging Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Clinical Trial Imaging Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Clinical Trial Imaging Sales Value, (2026-2031) & (US$ Million)
  • Table 31. ICON Basic Information List
  • Table 32. ICON Description and Business Overview
  • Table 33. ICON Clinical Trial Imaging Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Clinical Trial Imaging Business of ICON (2020-2025)
  • Table 35. ICON Recent Developments
  • Table 36. ERT Basic Information List
  • Table 37. ERT Description and Business Overview
  • Table 38. ERT Clinical Trial Imaging Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Clinical Trial Imaging Business of ERT (2020-2025)
  • Table 40. ERT Recent Developments
  • Table 41. McLaren Basic Information List
  • Table 42. McLaren Description and Business Overview
  • Table 43. McLaren Clinical Trial Imaging Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Clinical Trial Imaging Business of McLaren (2020-2025)
  • Table 45. McLaren Recent Developments
  • Table 46. Bioclinica Basic Information List
  • Table 47. Bioclinica Description and Business Overview
  • Table 48. Bioclinica Clinical Trial Imaging Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Clinical Trial Imaging Business of Bioclinica (2020-2025)
  • Table 50. Bioclinica Recent Developments
  • Table 51. Parexel Basic Information List
  • Table 52. Parexel Description and Business Overview
  • Table 53. Parexel Clinical Trial Imaging Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Clinical Trial Imaging Business of Parexel (2020-2025)
  • Table 55. Parexel Recent Developments
  • Table 56. BioTelemetry Basic Information List
  • Table 57. BioTelemetry Description and Business Overview
  • Table 58. BioTelemetry Clinical Trial Imaging Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Clinical Trial Imaging Business of BioTelemetry (2020-2025)
  • Table 60. BioTelemetry Recent Developments
  • Table 61. ProScan Imaging Basic Information List
  • Table 62. ProScan Imaging Description and Business Overview
  • Table 63. ProScan Imaging Clinical Trial Imaging Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Clinical Trial Imaging Business of ProScan Imaging (2020-2025)
  • Table 65. ProScan Imaging Recent Developments
  • Table 66. Imaging Endpoints Basic Information List
  • Table 67. Imaging Endpoints Description and Business Overview
  • Table 68. Imaging Endpoints Clinical Trial Imaging Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Clinical Trial Imaging Business of Imaging Endpoints (2020-2025)
  • Table 70. Imaging Endpoints Recent Developments
  • Table 71. Radiant Sage Basic Information List
  • Table 72. Radiant Sage Description and Business Overview
  • Table 73. Radiant Sage Clinical Trial Imaging Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Clinical Trial Imaging Business of Radiant Sage (2020-2025)
  • Table 75. Radiant Sage Recent Developments
  • Table 76. Micron, Inc. Basic Information List
  • Table 77. Micron, Inc. Description and Business Overview
  • Table 78. Micron, Inc. Clinical Trial Imaging Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Clinical Trial Imaging Business of Micron, Inc. (2020-2025)
  • Table 80. Micron, Inc. Recent Developments
  • Table 81. Intrinsic Imaging Basic Information List
  • Table 82. Intrinsic Imaging Description and Business Overview
  • Table 83. Intrinsic Imaging Clinical Trial Imaging Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Clinical Trial Imaging Business of Intrinsic Imaging (2020-2025)
  • Table 85. Intrinsic Imaging Recent Developments
  • Table 86. Median Technologies Basic Information List
  • Table 87. Median Technologies Description and Business Overview
  • Table 88. Median Technologies Clinical Trial Imaging Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Clinical Trial Imaging Business of Median Technologies (2020-2025)
  • Table 90. Median Technologies Recent Developments
  • Table 91. Cardiovascular Imaging Technologies Basic Information List
  • Table 92. Cardiovascular Imaging Technologies Description and Business Overview
  • Table 93. Cardiovascular Imaging Technologies Clinical Trial Imaging Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Clinical Trial Imaging Business of Cardiovascular Imaging Technologies (2020-2025)
  • Table 95. Cardiovascular Imaging Technologies Recent Developments
  • Table 96. Banook Medical Basic Information List
  • Table 97. Banook Medical Description and Business Overview
  • Table 98. Banook Medical Clinical Trial Imaging Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Clinical Trial Imaging Business of Banook Medical (2020-2025)
  • Table 100. Banook Medical Recent Developments
  • Table 101. IXICO Basic Information List
  • Table 102. IXICO Description and Business Overview
  • Table 103. IXICO Clinical Trial Imaging Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in Clinical Trial Imaging Business of IXICO (2020-2025)
  • Table 105. IXICO Recent Developments
  • Table 106. Tigermed Basic Information List
  • Table 107. Tigermed Description and Business Overview
  • Table 108. Tigermed Clinical Trial Imaging Products, Services and Solutions
  • Table 109. Revenue (US$ Million) in Clinical Trial Imaging Business of Tigermed (2020-2025)
  • Table 110. Tigermed Recent Developments
  • Table 111. Runda Medical Basic Information List
  • Table 112. Runda Medical Description and Business Overview
  • Table 113. Runda Medical Clinical Trial Imaging Products, Services and Solutions
  • Table 114. Revenue (US$ Million) in Clinical Trial Imaging Business of Runda Medical (2020-2025)
  • Table 115. Runda Medical Recent Developments
  • Table 116. Konica Minolta Basic Information List
  • Table 117. Konica Minolta Description and Business Overview
  • Table 118. Konica Minolta Clinical Trial Imaging Products, Services and Solutions
  • Table 119. Revenue (US$ Million) in Clinical Trial Imaging Business of Konica Minolta (2020-2025)
  • Table 120. Konica Minolta Recent Developments
  • Table 121. Keosys Basic Information List
  • Table 122. Keosys Description and Business Overview
  • Table 123. Keosys Clinical Trial Imaging Products, Services and Solutions
  • Table 124. Revenue (US$ Million) in Clinical Trial Imaging Business of Keosys (2020-2025)
  • Table 125. Keosys Recent Developments
  • Table 126. Key Raw Materials Lists
  • Table 127. Raw Materials Key Suppliers Lists
  • Table 128. Clinical Trial Imaging Downstream Customers
  • Table 129. Clinical Trial Imaging Distributors List
  • Table 130. Research Programs/Design for This Report
  • Table 131. Key Data Information from Secondary Sources
  • Table 132. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Clinical Trial Imaging Product Picture
  • Figure 2. Global Clinical Trial Imaging Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Clinical Trial Imaging Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Clinical Trial Imaging Report Years Considered
  • Figure 5. Global Clinical Trial Imaging Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Clinical Trial Imaging Revenue in 2024
  • Figure 7. Clinical Trial Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. In-house Imaging Service Picture
  • Figure 9. Central Imaging Service Picture
  • Figure 10. Global Clinical Trial Imaging Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 11. Global Clinical Trial Imaging Sales Value Market Share by Type, 2024 & 2031
  • Figure 12. Product Picture of Pharmaceutical Companies
  • Figure 13. Product Picture of Biotechnology Companies
  • Figure 14. Product Picture of Academic Institutes
  • Figure 15. Product Picture of Others
  • Figure 16. Global Clinical Trial Imaging Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 17. Global Clinical Trial Imaging Sales Value Market Share by Application, 2024 & 2031
  • Figure 18. North America Clinical Trial Imaging Sales Value (2020-2031) & (US$ Million)
  • Figure 19. North America Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
  • Figure 20. Europe Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 21. Europe Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
  • Figure 22. Asia Pacific Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. Asia Pacific Clinical Trial Imaging Sales Value by Region (%), 2024 VS 2031
  • Figure 24. South America Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. South America Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
  • Figure 26. Middle East & Africa Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 27. Middle East & Africa Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Key Countries/Regions Clinical Trial Imaging Sales Value (%), (2020-2031)
  • Figure 29. United States Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. United States Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
  • Figure 31. United States Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
  • Figure 32. Europe Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. Europe Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
  • Figure 34. Europe Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
  • Figure 35. China Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. China Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
  • Figure 37. China Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
  • Figure 38. Japan Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. Japan Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
  • Figure 40. Japan Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
  • Figure 41. South Korea Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. South Korea Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
  • Figure 43. South Korea Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
  • Figure 44. Southeast Asia Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. Southeast Asia Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
  • Figure 46. Southeast Asia Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
  • Figure 47. India Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. India Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031
  • Figure 49. India Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031
  • Figure 50. Clinical Trial Imaging Industrial Chain
  • Figure 51. Clinical Trial Imaging Manufacturing Cost Structure
  • Figure 52. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 53. Bottom-up and Top-down Approaches for This Report
  • Figure 54. Data Triangulation
  • Figure 55. Key Executives Interviewed